Gene plasticity in colonic circular smooth muscle cells underlies motility dysfunction in a model of postinfective IBS

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 296, Issue 3, 2009, Pages

  Choudhury, Barun K ^a   Shi, Xuan Zheng ^a   Sarna, Sushil K ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Enteric nervous system; Gastrointestinal motility; Gene expression; Irritable bowel syndrome; Neurotransmitters

Indexed keywords

ACETYLCHOLINE; CALCIUM CHANNEL L TYPE; MYOSIN LIGHT CHAIN; NORADRENALIN; TRINITROBENZENESULFONIC ACID; VASOACTIVE INTESTINAL POLYPEPTIDE; AUTACOID; CAV1.2 PROTEIN, MOUSE; CHOLINERGIC RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DEFECATION; DISEASE SEVERITY; ENTERITIS; EXCITATION CONTRACTION COUPLING; GENE EXPRESSION; INFECTION COMPLICATION; INTESTINAL DYSMOTILITY; INTESTINE CELL; IRRITABLE COLON; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; AGE; ANIMAL; COLON; CYTOLOGY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GASTROINTESTINAL MOTILITY; GENE EXPRESSION REGULATION; GENETICS; HOSPITALIZATION; IMMUNOLOGY; INNERVATION; INTESTINE INNERVATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ACETYLCHOLINE; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; CALCIUM CHANNELS, L-TYPE; CHOLINERGIC AGENTS; COLON; DEFECATION; DISEASE MODELS, ANIMAL; ENTERIC NERVOUS SYSTEM; ENTERITIS; GASTROINTESTINAL MOTILITY; GENE EXPRESSION REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; INFLAMMATION MEDIATORS; IRRITABLE BOWEL SYNDROME; MALE; MYOCYTES, SMOOTH MUSCLE; MYOSIN LIGHT CHAINS; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 65349095651     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90673.2008     Document Type: Article

References (47)

1. Al-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 119: 1276-1285, 2000.
2. Barreau F, Cartier C, Ferrier L, Fioramonti J, Bueno L. Nerve growth factor mediates alterations of colonic sensitivity and mucosal barrier induced by neonatal stress in rats. Gastroenterology 127: 524-534, 2004.
3. Bergin AJ, Donnely TC, McKendrik MW, Read NW. Changes in anorectal function in persistent bowel disturbance following salmonella gastroenteritis. Eur J Gastroenterol Hepatol 5: 617-620, 1993.
4. Bueno L, Fioramonti J, Ruckebusch Y, Frexinos J, Coulom P. Evaluation of colonic myoelectrical activity in health and functional disorders. Gut 21: 480-485, 1980.
5. Camilleri M, Ford MJ. Review article: colonic sensorimotor physiology in health, and its alteration in constipation and diarrhoeal disorders. Aliment Pharmacol Ther 12: 287-302, 1998.
6. Cann PA, Read NW, Brown C, Hobson N, Holdsworth CD. Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut 24: 405-411, 1983.
7. Carrasco GA, Van de Kar LD. Neuroendocrine pharmacology of stress. Eur J Pharmacol 463: 235-272, 2003.
8. Chaudhary NA, Truelove SC. The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med 31: 307-322, 1962.
9. Collins SM, Blennerhassett PA, Blennerhassett MG, Vermillion DL. Impaired acetylcholine release from the myenteric plexus of Trichinella-infected rats. Am J Physiol Gastrointest Liver Physiol 257: G898-G903, 1989.
10. Coutinho SV, Plotsky PM, Sablad M, Miller JC, Zhou H, Bayati AI, McRoberts JA, Mayer EA. Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am J Physiol Gastrointest Liver Physiol 282: G307-G316, 2002.
11. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 123: 2108-2131, 2002.
12. Drossman DA, Leserman J, Nachman G, Li ZM, Gluck H, Toomey TC, Mitchell CM. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med 113: 828-833, 1990.
13. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 98: 1578-1583, 2003.
14. Freud S. Mourning and melancholia. In: The Complete Works. London: Hogarth, 1917.
15. Gwee KA, Graham JC, McKendrick MW, Collins SM, Marshall JS, Walters SJ, Read NW. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 347: 150-153, 1996.
16. Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Walters SJ, Underwood JE, Read NW. The role of psychological and biological factors in postinfective gut dysfunction. Gut 44: 400-406, 1999.
17. Halvorson HA, Schlett CD, Riddle MS. Postinfectious irritable bowel syndrome - a meta-analysis. Am J Gastroenterol 101: 1894-1899; quiz 1942, 2006.
18. Heitkemper M, Jarrett M, Cain K, Shaver J, Bond E, Woods NF, Walker E. Increased urine catecholamines and cortisol in women with irritable bowel syndrome. Am J Gastroenterol 91: 906-913, 1996.
19. Hislop IG. Childhood deprivation: an antecedent of the irritable bowel syndrome. Med J Aust 1: 372-374, 1979.
20. Levine S. Infantile experience and resistance to physiological stress. Science 126: 405, 1957.
21. Liu X, Rusch NJ, Striessnig J, Sarna SK. Down-regulation of L-type calcium channels in inflamed circular smooth muscle cells of the canine colon. Gastroenterology 120: 480-489, 2001.
22. Mazur M, Furgala A, Jablonski K, Madroszkiewicz D, Ciecko-Michalska I, Bugajski A, Thor PJ. Dysfunction of the autonomic nervous system activity is responsible for gastric myoelectric disturbances in the irritable bowel syndrome patients. J Physiol Pharmacol 58, Suppl 3: 131-139, 2007.
23. McKendrick MW, Read NW. Irritable bowel syndrome - post salmonella infection. J Infect 29: 1-3, 1994.
24. Mearin F, Perez-Oliveras M, Perello A, Vinyet J, Ibanez A, Coderch J, Perona M. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 129: 98-104, 2005.
25. Miller DB, O'Callaghan JP. Neuroendocrine aspects of the response to stress. Metabolism 51: 5-10, 2002.
26. Murthy KS. Signaling for contraction and relaxation in smooth muscle of the gut. Annu Rev Physiol 68: 345-374, 2006.
27. Murthy KS, Zhou H, Grider JR, Brautigan DL, Eto M, Makhlouf GM. Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway. Biochem J 374: 145-155, 2003.
28. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. Br Med J 314: 779-782, 1997.
29. Palsson OS, Morteau O, Bozymski EM, Woosley JT, Sartor RB, Davies MJ, Johnson DA, Turner MJ, Whitehead WE. Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome. Dig Dis Sci 49: 1236-1243, 2004.
30. Parry SD, Stansfield R, Jelley D, Gregory W, Phillips E, Barton JR, Welfare MR. Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. Am J Gastroenterol 98: 1970-1975, 2003.
31. Posserud I, Agerforz P, Ekman R, Bjornsson ES, Abrahamsson H, Simren M. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 53: 1102-1108, 2004.
32. Rogers J, Henry MM, Misiewicz JJ. Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with irritable bowel syndrome. Gut 30: 634-641, 1989.
33. Saklatvala J. Glucocorticoids: do we know how they work? Arthritis Res 4: 146-150, 2002.
34. Sallam HS, Oliveira HM, Gan HT, Herndon DN, Chen JD. Ghrelin improves burn-induced delayed gastrointestinal transit in rats. Am J Physiol Regul Integr Comp Physiol 292: R253-R257, 2007.
35. Sarna SK. Molecular, functional and pharmacological targets for the development of gut promotility drugs. Am J Physiol Gastrointest Liver Physiol 292: G545-G555, 2006.
36. Sarna SK, Shi XZ. Function and regulation of colonic contractions in health and disease. In: Physiology of the Gastrointestinal Tract, 4th edition. Eds: Johnson LR, Barret KE, Gishan FK, Merchant JL, Said H, Wood JD. San Diego, CA: Elsevier, 2006, p. 965-993.
37. Schwetz I, McRoberts JA, Coutinho SV, Bradesi S, Gale G, Fanselow M, Million M, Ohning G, Tache Y, Plotsky PM, Mayer EA. Corticotropin-releasing factor receptor 1 mediates acute and delayed stressinduced visceral hyperalgesia in maternally separated Long-Evans rats. Am J Physiol Gastrointest Liver Physiol 289: G704-G712, 2005.
38. Shi XZ, Choudhury BK, Pasricha PJ, Sarna SK. A novel role of VIP in colonic motility function: induction of excitation-transcription coupling in smooth muscle cells. Gastroenterology 132: 1388-1400, 2007.
39. Shi XZ, Pazdrak K, Saada N, Dai B, Palade P, Sarna SK. Negative transcriptional regulation of human colonic smooth muscle Cav1.2 channels by p50 and p65 subunits of nuclear factor-kappaB. Gastroenterology 129: 1518-1532, 2005.
40. Shi XZ, Sarna SK. Gene therapy of Cav1.2 channel with VIP and VIP receptor agonists and antagonists: a novel approach to designing promotility and antimotility agents. Am J Physiol Gastrointest Liver Physiol 295: G187-G196, 2008.
41. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and non-muscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
42. Spencer SJ, Boisse L, Mouihate A, Pittman QJ. Long term alterations in neuroimmune responses of female rats after neonatal exposure to lipopolysaccharide. Brain Behav Immun 20: 325-330, 2006.
43. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47: 804-811, 2000.
44. Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study. Gut 42: 47-53, 1998.
45. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53: 865-871, 2002.
46. Walker EA, Katon WJ, Roy-Byrne PP, Jemelka RP, Russo J. Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry 150: 1502-1506, 1993.
47. Whitehead WE, Crowell MD, Davidoff AL, Palsson OS, Schuster MM. Pain from rectal distension in women with irritable bowel syndrome: relationship to sexual abuse. Dig Dis Sci 42: 796-804, 1997.